Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |